1986 - Member of the National Academy of Sciences
Member of the Association of American Physicians
Internal medicine is closely attributed to Receptor in his research. His Receptor study frequently draws connections to adjacent fields such as Internal medicine. His study connects Pancreas and Endocrinology. His research links Hyperglucagonemia with Insulin. His Insulin research extends to the thematically linked field of Hyperglucagonemia. His research brings together the fields of Lipotoxicity and Diabetes mellitus. He integrates many fields in his works, including Lipotoxicity and Obesity. Roger H Unger performs integrative Obesity and Insulin resistance research in his work. While working on this project, Roger H Unger studies both Insulin resistance and Leptin.
Roger H Unger integrates Endocrinology with Hormone in his study. Hormone and Glucagon are two areas of study in which he engages in interdisciplinary work. As part of his studies on Internal medicine, Roger H Unger often connects relevant areas like Receptor. His Receptor study typically links adjacent topics like Internal medicine. Roger H Unger performs multidisciplinary study in the fields of Insulin and Insulin resistance via his papers. While working on this project, he studies both Insulin resistance and Insulin. His Diabetes mellitus study frequently draws connections between related disciplines such as Islet. Roger H Unger combines topics linked to Diabetes mellitus with his work on Islet. Biochemistry is often connected to Glucagon in his work.
Roger H Unger is exploring Glucagon as part of his Glucagon receptor and Hyperglucagonemia and Glucagon studies. His Insulin resistance study is within the categories of Lipotoxicity and Glucose homeostasis. His research on Endocrinology frequently links to adjacent areas such as Leptin. He performs multidisciplinary study on Leptin and Obesity in his works. His multidisciplinary approach integrates Obesity and Metabolic syndrome in his work. Roger H Unger integrates Metabolic syndrome with Insulin resistance in his research. His Internal medicine study frequently links to other fields, such as Glucose homeostasis. In his papers, Roger H Unger integrates diverse fields, such as Diabetes mellitus and Type 2 diabetes. In his papers, he integrates diverse fields, such as Type 2 diabetes and Insulin.
Roger H Unger is researching Glucagon as part of the investigation of Hyperglucagonemia and Glucagon receptor. His Biochemistry research extends to Hyperglucagonemia, which is thematically connected. In most of his Biochemistry studies, his work intersects topics such as Glucagon receptor. Internal medicine is closely attributed to Steatosis in his research. Roger H Unger performs integrative study on Steatosis and Insulin resistance in his works. Roger H Unger performs multidisciplinary studies into Insulin resistance and Hypoglycemia in his work. Roger H Unger integrates Hypoglycemia and Insulin in his studies. His Insulin study frequently links to other fields, such as Glucose homeostasis. Endocrinology is closely attributed to Calorie in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications
Roger H Unger.
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Michio Shimabukuro;Yan Ting Zhou;Yan Ting Zhou;Moshe Levi;Roger H Unger.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Lipotoxic heart disease in obese rats: implications for human obesity.
Yan Ting Zhou;Paul Grayburn;Paul Grayburn;Asad Karim;Asad Karim;Michio Shimabukuro;Michio Shimabukuro.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Studies of pancreatic alpha cell function in normal and diabetic subjects
Roger H. Unger;E. Aguilar-Parada;Walter A. Müller;Anna M. Eisentraut.
Journal of Clinical Investigation (1970)
Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome
Roger H Unger.
DIRECT ANTIDIABETIC EFFECT OF LEPTIN THROUGH TRIGLYCERIDE DEPLETION OF TISSUES
Michio Shimabukuro;Kazunori Koyama;Guoxun Chen;May-Yun Wang.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.
Walter A. Müller;Gerald R. Faloona;Eugenio Aguilar-Parada;Roger H. Unger.
The New England Journal of Medicine (1970)
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.
Roger H. Unger;Alan D. Cherrington.
Journal of Clinical Investigation (2012)
Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients
M. D. Siperstein;Roger H Unger;L. L. Madison.
Journal of Clinical Investigation (1968)
Pancreatic Glucagon Secretion in Normal and Diabetic Subjects
E. Aguilar-Parada;A. M. Eisentraut;Roger H Unger.
The American Journal of the Medical Sciences (1969)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: